redcare pharmacy nv - SHPPF

SHPPF

Close Chg Chg %
75.00 -0.28 -0.37%

Closed Market

74.72

-0.28 (0.37%)

Volume: 4.00

Last Updated:

Jan 8, 2026, 9:53 AM EDT

Company Overview: redcare pharmacy nv - SHPPF

SHPPF Key Data

Open

$74.72

Day Range

74.72 - 74.72

52 Week Range

67.96 - 148.22

Market Cap

$1.57B

Shares Outstanding

20.36M

Public Float

15.27M

Beta

1.43

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.86

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

6.38

 

SHPPF Performance

1 Week
 
-0.37%
 
1 Month
 
4.44%
 
3 Months
 
-46.49%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

SHPPF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About redcare pharmacy nv - SHPPF

Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.

SHPPF At a Glance

Redcare Pharmacy NV
Erik de Rodeweg 11/13
Sevenum, Limburg 5975 WD
Phone N/A Revenue 2.56B
Industry Medical Distributors Net Income -49,177,988.55
Sector Distribution Services 2024 Sales Growth 31.86%
Fiscal Year-end 12 / 2025 Employees 2,266
View SEC Filings

SHPPF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.067
Price to Book Ratio 5.854
Price to Cash Flow Ratio 125.75
Enterprise Value to EBITDA 91.729
Enterprise Value to Sales 1.118
Total Debt to Enterprise Value 0.101

SHPPF Efficiency

Revenue/Employee 1,131,610.355
Income Per Employee -21,702.555
Receivables Turnover 19.834
Total Asset Turnover 2.307

SHPPF Liquidity

Current Ratio 2.002
Quick Ratio 1.386
Cash Ratio 0.711

SHPPF Profitability

Gross Margin 20.145
Operating Margin -1.659
Pretax Margin -2.035
Net Margin -1.918
Return on Assets -4.425
Return on Equity -9.737
Return on Total Capital -6.501
Return on Invested Capital -6.214

SHPPF Capital Structure

Total Debt to Total Equity 61.519
Total Debt to Total Capital 38.088
Total Debt to Total Assets 27.072
Long-Term Debt to Equity 59.368
Long-Term Debt to Total Capital 36.756
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Redcare Pharmacy Nv - SHPPF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.25B 1.27B 1.94B 2.56B
Sales Growth
+13.57% +0.99% +53.64% +31.86%
Cost of Goods Sold (COGS) incl D&A
970.07M 958.57M 1.53B 2.05B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
31.82M 41.53M 61.93M 73.79M
Depreciation
13.45M 14.54M 17.33M 19.55M
Amortization of Intangibles
18.37M 26.99M 44.60M 54.24M
COGS Growth
+11.29% -1.19% +59.66% +33.79%
Gross Income
283.21M 307.17M 414.17M 516.57M
Gross Income Growth
+22.10% +8.46% +34.83% +24.73%
Gross Profit Margin
+22.60% +24.27% +21.30% +20.15%
2021 2022 2023 2024 5-year trend
SG&A Expense
334.52M 364.83M 432.27M 559.12M
Research & Development
- - - -
-
Other SG&A
334.52M 364.83M 432.27M 559.12M
SGA Growth
+43.57% +9.06% +18.48% +29.35%
Other Operating Expense
- - - -
-
Unusual Expense
- 26.72M 16.71M (12.95M)
EBIT after Unusual Expense
(78.03M) (74.37M) (5.15M) (42.55M)
Non Operating Income/Expense
1.98M 641.09K 6.11M (928.09K)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
15.51M 15.03M 16.72M 8.72M
Interest Expense Growth
-6.65% -3.06% +11.20% -47.86%
Gross Interest Expense
15.51M 15.03M 16.72M 8.72M
Interest Capitalized
- - - -
-
Pretax Income
(91.55M) (88.76M) (15.76M) (52.19M)
Pretax Income Growth
-402.67% +3.05% +82.25% -231.23%
Pretax Margin
-7.31% -7.01% -0.81% -2.04%
Income Tax
(4.37M) (6.80M) (2.96M) (1.60M)
Income Tax - Current - Domestic
665.46K (55.70K) 1.06M 699.85K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(5.04M) (6.75M) (4.02M) (2.30M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(87.69M) (81.60M) (12.55M) (50.14M)
Minority Interest Expense
- - 470.29K (964.87K)
-
Net Income
(87.69M) (81.60M) (13.02M) (49.18M)
Net Income Growth
-358.64% +6.94% +84.05% -277.78%
Net Margin Growth
-7.00% -6.45% -0.67% -1.92%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(87.69M) (81.60M) (13.02M) (49.18M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(87.69M) (81.60M) (13.02M) (49.18M)
EPS (Basic)
-4.9032 -4.5374 -0.6766 -2.4523
EPS (Basic) Growth
-268.77% +7.46% +85.09% -262.44%
Basic Shares Outstanding
17.88M 17.98M 19.24M 20.05M
EPS (Diluted)
-4.9032 -4.5374 -0.6766 -2.4523
EPS (Diluted) Growth
-268.77% +7.46% +85.09% -262.44%
Diluted Shares Outstanding
17.88M 17.98M 19.24M 20.05M
EBITDA
(19.48M) (16.13M) 43.84M 31.24M
EBITDA Growth
-212.95% +17.21% +371.73% -28.73%
EBITDA Margin
-1.55% -1.27% +2.25% +1.22%

Redcare Pharmacy Nv in the News